NCT00476086View on ClinicalTrials.gov

Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

March 31, 2012

Study Completion Date

December 31, 2015

Conditions
Mixed Mullerian Tumors of the Uterus
Interventions
DRUG

Gemcitabine

DRUG

Oxaliplatin

RADIATION

Radiation

Trial Locations (2)

02115

Dana-Farber Cancer Institute, Boston

02215

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

collaborator

Brigham and Women's Hospital

OTHER

collaborator

Massachusetts General Hospital

OTHER

lead

Dana-Farber Cancer Institute

OTHER